<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">
Cryoport transportation image

When you need confidence in your cold chain… Trust Cryoport

Request a Quote

Upcoming Events View All


World Stem Cell Summit 2016

Date: December 6-9, 2016
Location: West Palm Beach, FL


Southwest Embryology Summit

Date: January 6-7, 2017
Location: Phoenix, AZ


The Latest From Our Blog View All

Using Real-World Data to Reduce Cold Chain Risk

When planning your cold chain logistics strategy for temperature-sensitive biologic materials, a key consideration is minimizing risk to the quality of the commodity and its on-time delivery. Today, there are tools available that optimize outcomes by using real-world data to create better predictive models for the delivery of shipments anywhere in the world.

Providing a Logistics Management Solution for Biologic Commodity Transport

Autologous cell and gene therapy processes start and end with the patient, so the transport and storage of these biologic materials pose complex logistical challenges. Depending on the severity of the patient’s illness, there may be limited opportunities for sample collection and, consequently, manufacture of the potential therapy. Furthermore, any variation in temperature or any interruption in the supply chain, can delay delivery and administration of the therapy to the patient. Irregularities in the cold chain may also affect clinical trial results by compromising data integrity as well as product efficacy and safety. To address these challenges, Cryoport and Database Integrations have launched an integrated solution to manage patient and manufacturer scheduling logistics at every stage of the supply chain for both clinical trial and commercialization processes.